Effect of Natural Honey on Glycemic Control and Anthropometric Measures of Patients with Type 2 Diabetes: A Randomized Controlled Crossover Trial
- PMID: 30774837
- PMCID: PMC6360845
- DOI: 10.4103/ijpvm.IJPVM_109_18
Effect of Natural Honey on Glycemic Control and Anthropometric Measures of Patients with Type 2 Diabetes: A Randomized Controlled Crossover Trial
Abstract
Background: Due to high content of fructose, honey has been introduced as a suitable natural sweetener for patients with type 2 diabetes. We investigated the effect of honey consumption on glycemic control and anthropometric measures of patients with type 2 diabetes.
Methods: This randomized controlled crossover clinical trial was conducted on 53 patients with type 2 diabetes. The participants were randomly divided into groups of control (weight maintenance diet) or treatment (weight maintenance diet +50 g/day honey) for 8 weeks. After a 4-week washout, the second phase began, in which the role of the groups was interchanged. Blood glycated hemoglobin (HbA1c), glucose, insulin, and anthropometric characteristics were measured. Statistical analysis was performed with SPSS. Repeated measures of ANOVA were used to test differences within- and between the two conditions.
Results: Forty-two patients completed the study. HbA1c significantly decreased in control (-0.22%, P = 0.03) and nonsignificantly increased in honey condition (+0.17%, P = 0.22). There was a significant difference between the two conditions (P = 0.02). Fasting glucose did not significantly change in either honey or control condition but insulin concentrations (-0.85 μU/ml, P = 0.01) and insulin secretion (-10.7%, P = 0.01) decreased significantly in the control condition. There was no significant difference in any of these parameters between the two conditions. Waist circumference decreased by honey treatment with a significant difference between the two conditions (P = 0.02).
Conclusions: Eight weeks consumption of 50 g/day honey increased HbA1c and decreased waist circumference of patients with type 2 diabetes.
Keywords: Diabetes mellitus; honey; insulin resistance; type 2; waist circumference.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Metabolic effects of honey in type 1 diabetes mellitus: a randomized crossover pilot study.J Med Food. 2013 Jan;16(1):66-72. doi: 10.1089/jmf.2012.0108. Epub 2012 Dec 20. J Med Food. 2013. PMID: 23256446 Clinical Trial.
-
Adverse effects of honey on low-density lipoprotein cholesterol and adiponectin concentrations in patients with type 2 diabetes: a randomized controlled cross-over trial.J Diabetes Metab Disord. 2020 Apr 14;19(1):373-380. doi: 10.1007/s40200-020-00518-z. eCollection 2020 Jun. J Diabetes Metab Disord. 2020. PMID: 32550188 Free PMC article.
-
Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.Clin Ther. 2004 Sep;26(9):1427-35. doi: 10.1016/j.clinthera.2004.09.017. Clin Ther. 2004. PMID: 15531005 Clinical Trial.
-
Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial.Int J Food Sci Nutr. 2009 Nov;60(7):618-26. doi: 10.3109/09637480801990389. Int J Food Sci Nutr. 2009. PMID: 19817641 Clinical Trial.
-
Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.Diabetes Ther. 2020 Mar;11(3):573-584. doi: 10.1007/s13300-019-00732-w. Epub 2019 Dec 23. Diabetes Ther. 2020. PMID: 31873857 Free PMC article. Review.
Cited by
-
Honey vesicle-like nanoparticles protect aged liver from non-alcoholic steatohepatitis.Acta Pharm Sin B. 2024 Aug;14(8):3661-3679. doi: 10.1016/j.apsb.2024.05.002. Epub 2024 May 10. Acta Pharm Sin B. 2024. PMID: 39220874 Free PMC article.
-
Non-nutritive sweeteners for diabetes mellitus.Cochrane Database Syst Rev. 2020 May 25;5(5):CD012885. doi: 10.1002/14651858.CD012885.pub2. Cochrane Database Syst Rev. 2020. PMID: 32449201 Free PMC article.
-
Comparable Benefits of Stingless Bee Honey and Caffeic Acid in Mitigating the Negative Effects of Metabolic Syndrome on the Brain.Antioxidants (Basel). 2022 Oct 31;11(11):2154. doi: 10.3390/antiox11112154. Antioxidants (Basel). 2022. PMID: 36358526 Free PMC article.
-
The Effects of Oral Consumption of Honey on Key Metabolic Profiles in Adult Patients with Type 2 Diabetes Mellitus and Nondiabetic Individuals: A Systematic Review of Clinical Trials.Evid Based Complement Alternat Med. 2021 Jan 23;2021:6666832. doi: 10.1155/2021/6666832. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33552217 Free PMC article. Review.
-
Apitherapy for diabetes mellitus: mechanisms and clinical implications.J Complement Integr Med. 2025 Jan 1;22(2):228-236. doi: 10.1515/jcim-2024-0367. eCollection 2025 Jun 1. J Complement Integr Med. 2025. PMID: 39743810 Review.
References
-
- Virginia A American Diabetes Association Releases New Nutritional Guidelines. [Last updated on 2017 Dec 08]. Available from: http://www.diabetes.org/ newsroom/press-releases/2017/american-diabetes-... .
-
- Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: A review. J Am Coll Nutr. 2008;27:677–89. - PubMed
-
- Deibert P, König D, Kloock B, Groenefeld M, Berg A. Glycaemic and insulinaemic properties of some German honey varieties. Eur J Clin Nutr. 2010;64:762–4. - PubMed
-
- Ischayek JI, Kern M. US honeys varying in glucose and fructose content elicit similar glycemic indexes. J Am Diet Assoc. 2006;106:1260–2. - PubMed